Regulus Therapeutics
RGLS
#6949
Rank
NZ$0.98 B
Marketcap
NZ$14.17
Share price
0.00%
Change (1 day)
448.25%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : NZ$10.06 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are NZ$10.06 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$13.78 M-8.86%
2023-12-31NZ$15.12 M-28.49%
2022-12-31NZ$21.14 M7.02%
2021-12-31NZ$19.75 M23.14%
2020-12-31NZ$16.04 M-51.03%
2019-12-31NZ$32.76 M-34.94%
2018-12-31NZ$50.36 M-16.03%
2017-12-31NZ$59.97 M-6.83%
2016-12-31NZ$64.36 M159.06%
2015-12-31NZ$24.84 M-50.67%
2014-12-31NZ$50.37 M39.8%
2013-12-31NZ$36.02 M-28.45%
2012-12-31NZ$50.35 M-53.42%
2011-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GlaxoSmithKline
GSK
NZ$106.40 B 1,056,892.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
NZ$114.63 B 1,138,690.96%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$19.09 B 189,620.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.90 B 1,181,083.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
NZ$8.01 B 79,544.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.14 B 1,321.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$135.92 B 1,350,175.96%๐Ÿ‡บ๐Ÿ‡ธ USA